IBM.TO is trading 3.05% down after profit-taking on its finalized US$1 billion quantum-wafer CHIPS Act award; CDR liquidity and price discovery may have amplified the move.
- U.S. technology shares were generally supported by easing Treasury yields and lower oil prices; major indexes were only modestly lower.
- No scheduled earnings release or major company-specific event was noted for September 18, 2026.
- The Fed’s September 16 rate hike remains a background valuation risk; no single confirmed catalyst explains the drop.